| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.2M | +497.8% |
| SG&A Expense | $7.1M | +12.0% |
| Operating Income | -$21.2M | -137.8% |
| Net Income | -$13.9M | -55.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $47.5M | -32.6% |
| Total Assets | $51.1M | -27.9% |
| Current Liabilities | $6.8M | +177.1% |
| Total Liabilities | $6.8M | +171.4% |
| Stockholders' Equity | $44.3M | -35.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.8M | -104.5% |
| Capital Expenditures | $338K | +2314.3% |
| Investing Cash Flow | -$338K | -2314.3% |
| Financing Cash Flow | $63.4M | -16.2% |
| Free Cash Flow | -$19.1M | -107.8% |